TGFB1 and gastric cancer: The mesenchymal phenotype has been linked to treatment resistance and has been explored with ST in gastric cancer, with the discovery of gastric cancer cells in a partial epithelial–mesenchymal transition state characterized by TGF-β signaling (Jang et al. 2023).